Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1988 1
1989 1
1990 3
1991 1
1992 4
1993 3
1994 4
1995 4
1996 7
1997 6
1998 7
1999 3
2000 5
2001 3
2002 4
2003 3
2004 4
2005 8
2006 3
2007 9
2008 4
2009 5
2010 5
2011 3
2012 11
2013 10
2014 8
2015 3
2016 4
2017 7
2018 4
2020 3
2021 1
Text availability
Article attribute
Article type
Publication date

Search Results

141 results
Results by year
Filters applied: . Clear all
Page 1
Ribonucleotide reductase inhibitors suppress SAMHD1 ara-CTPase activity enhancing cytarabine efficacy.
Rudd SG, Tsesmetzis N, Sanjiv K, Paulin CB, Sandhow L, Kutzner J, Hed Myrberg I, Bunten SS, Axelsson H, Zhang SM, Rasti A, Mäkelä P, Coggins SA, Tao S, Suman S, Branca RM, Mermelekas G, Wiita E, Lee S, Walfridsson J, Schinazi RF, Kim B, Lehtiö J, Rassidakis GZ, Pokrovskaja Tamm K, Warpman-Berglund U, Heyman M, Grandér D, Lehmann S, Lundbäck T, Qian H, Henter JI, Schaller T, Helleday T, Herold N. Rudd SG, et al. Among authors: grander d. EMBO Mol Med. 2020 Mar 6;12(3):e10419. doi: 10.15252/emmm.201910419. Epub 2020 Jan 17. EMBO Mol Med. 2020. PMID: 31950591 Free PMC article.
Irreversible TrxR1 inhibitors block STAT3 activity and induce cancer cell death.
Busker S, Qian W, Haraldsson M, Espinosa B, Johansson L, Attarha S, Kolosenko I, Liu J, Dagnell M, Grandér D, Arnér ESJ, Tamm KP, Page BDG. Busker S, et al. Among authors: grander d. Sci Adv. 2020 Mar 20;6(12):eaax7945. doi: 10.1126/sciadv.aax7945. eCollection 2020 Mar. Sci Adv. 2020. PMID: 32219156 Free PMC article.
Autophagy: cancer therapy's friend or foe?
Grandér D, Panaretakis T. Grandér D, et al. Future Med Chem. 2010 Feb;2(2):285-97. doi: 10.4155/fmc.09.155. Future Med Chem. 2010. PMID: 21426194 Review.
An emerging role for long non-coding RNAs in cancer metastasis.
Serviss JT, Johnsson P, Grandér D. Serviss JT, et al. Among authors: grander d. Front Genet. 2014 Jul 18;5:234. doi: 10.3389/fgene.2014.00234. eCollection 2014. Front Genet. 2014. PMID: 25101115 Free PMC article. Review.
Silencing of CEBPB-AS1 modulates CEBPB expression and resensitizes BRAF-inhibitor resistant melanoma cells to vemurafenib.
Vidarsdottir L, Fernandes RV, Zachariadis V, Das I, Edsbäcker E, Sigvaldadottir I, Azimi A, Höiom V, Hansson J, Grandér D, Egyházi Brage S, Pokrovskaja Tamm K. Vidarsdottir L, et al. Among authors: grander d. Melanoma Res. 2020 Oct;30(5):443-454. doi: 10.1097/CMR.0000000000000675. Melanoma Res. 2020. PMID: 32467529 Free PMC article.
141 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page